Akebia Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Akebia Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Akebia Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.5M, a 4.07% increase year-over-year.
  • Akebia Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$34.8M, a 33.7% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$46.3M, a 42.7% increase from 2022.
  • Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$80.8M, a 69.5% increase from 2021.
  • Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$265M, a 30% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$46.3M +$34.5M +42.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$80.8M +$184M +69.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$265M +$113M +30% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 -$378M -$91.5M -32% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 -$286M -$108M -60.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$178M -$101M -132% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$76.7M +$59.8M +43.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$136M -$74.9M -122% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
2015 -$61.5M -$23.6M -62.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$37.9M -$22M -138% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 -$15.9M -$7.41M -86.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$8.52M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.